Edwards CEO Mussallem announces stock plans | Personnel Moves

May 7, 2012 by MassDevice staff

Edwards Lifesciences chairman & CEO Michael Mussallem will in May begin exercising his stock options under SEC rule 10b5-1; also SRS Medical promotes Lee Brody to the corner office; Advanced Cardiac Therapeutics shuffles the deck, builds its hand to support commercialization; CardioKinetix names Maria Sainz president & CEO; Zeltiq interim president & CEO Mark Foley to receive $50k per month; and more.


 Edwards' CEO Mussallem exercises stock options
Edwards Lifesciences (NYSE:EW) chairman & CEO Michael Mussallem will this month begin exercising stock options that were nearing expiration through a pre-arranged stock trading plan under SEC rule 10b5-1.

The plan allows Mussallem to exercise and sell up to 35,000 shares per month with the intent of spreading sales smoothly over an extended period of time. Under Edwards policy, Mussallem must hold EW shares worth at least 6 times his base salary and at the conclusion of his planned sell-off he will still hold shares "well in excess" of that guideline, according to a press release.

EW shares were up 0.6% to $85.49 as of about 4:15 p.m. today. Read more